TP53 and cancer: With these findings, one cannot be confident in asserting that the TP53 gene is less mutated in Rwandan cancer or in Africa compared to Europe, Latin America or Asia since studies done on the African continent analyzing TP53 mutations in gastric cancer are still lacking [24, 59].